Interdisciplinary Teams

Members of the Infectious Disease Research and Response Network and their collaborators have come together to form interdisciplinary teams pursuing collaborative research on the below topics.

Community Engaged Education to Address Misinformation about Health Issues

Using community-based approaches in science communication to understand the dynamics of trust in different sources of information for emerging science and risk issues.

Lead: Ashley Anderson, Ph.D. (Journalism and Media Communication)

Members:

  • Colleen Duncan, D.V.M. Ph.D.(Microbiology, Immunology, and Pathology)
  • Marilee Long, Ph.D. (Journalism and Media Communication, Environmental Affairs)
  • Nicole Kelp, Ph.D. (Microbiology, Immunology ,and Pathology)
  • Candace Mathiason, Ph.D. (Microbiology, Immunology, and Pathology)
  • Gaya Sivakumar, Ph.D. (Journalism and Media Communication)
  • Sue VandeWoude, D.V.M. (One Health Institute at Colorado State University, Microbiology, Immunology, and Pathology)

 

Companion Animal Cognitive Disorder

Cognitive dysfunction syndrome is a well-documented syndrome in older canines and has recently been gaining recognition in the senior feline population. Diagnosis and treatment remain elusive. We are working to establish a standardized method for diagnosis, as well as treatment options for this syndrome.

Lead: Julie Moreno, Ph.D. (Environmental and Radiological Health Sciences)

Members:

  • Lisa Bartner, D.V.M. (Clinical Sciences)
  • Steve Dow, D.V.M., Ph.D. (Clinical Sciences)
  • Colleen Duncan, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Nicole Ehrhart, V.M.D. (Columbine Health Systems Center for Healthy Aging)
  • Andrew Jones, Ph.D. (Cooperative Institute for Research in the Atmosphere)
  • Lori Kogan, Ph.D. (Clinical Sciences)
  • Nicole Kruh-Garcia, Ph.D. (BioMARC)
  • Doreen Martinez, Ph.D. (Ethnic Studies)
  • Candace Mathiason, Ph.D. (Microbiology, Immunology, and Pathology)
  • Stephanie McGrath, D.V.M. (Clinical Sciences)
  • Rebecca Packer, D.V.M. (Clinical Sciences)
  • Stuart Tobet, Ph.D. (Biomedical Sciences)
  • Craig Webb, D.V.M., Ph.D. (Clinical Sciences)
  • Tracy Webb, D.V.M., Ph.D. (Clinical Sciences)

COVID-19

The recognition of novel pathogens with capacity to cross the species barriers has once again become evident with the recent COVID-19 outbreak. Research established to understand these events from a multi-pronged interdisciplinary perspective will advance our understanding of this and future disease emergence.

COVID-19 Efforts of MIP Faculty & Collaborators in the IDRRN

Lead: Candace Mathiason, Ph.D. (Microbiology, Immunology, and Pathology)

Members:

  • Zaid Abdo, Ph.D. (Microbiology, Immunology, and Pathology)
  • Tawfik Aboellail, B.V.Sc., Ph.D. (Microbiology, Immunology, and Pathology)
  • Ramesh Akkina, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Randy Basaraba, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Angela Bosco-Lauth, D.V.M., Ph.D. (Biomedical Sciences)
  • Richard Bowen, D.V.M., Ph.D. (Biomedical Sciences)
  • Jifeng Bian, D.M.D., Ph.D. (Microbiology, Immunology, and Pathology)
  • Adam Chicco, Ph.D. (Biomedical Sciences)
  • Hamid Chitsaz, Ph.D. (Computer Science)
  • Lyndah Chow, M.S. (Clinical Sciences)
  • David Dandy, Ph.D. (Chemical and Biological Engineering)
  • Gregg Dean, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Karen Dobos, Ph.D. (Microbiology, Immunology, and Pathology)
  • Steve Dow, D.V.M., Ph.D. (Clinical Sciences)
  • Coleen Duncan, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Gregory Ebel, Sc.D. (Microbiology, Immunology, and Pathology)
  • Brian Edwards (Google)
  • Nicole Ehrhart, V.M.D. (Columbine Health Systems Center for Healthy Aging)
  • Robert Ellis, Ph.D. (Microbiology, Immunology, and Pathology)
  • Brian Foy, Ph.D. (Microbiology, Immunology, and Pathology)
  • Danielle Frey, D.V.M. (College of Veterinary Medicine and Biomedical Sciences)
  • Ray Goodrich, Ph.D. (Infectious Disease Research Center)
  • Brian Geiss, Ph.D. (Microbiology, Immunology, and Pathology)
  • Marcela Henao-Tamayo, M.D., Ph.D. (Microbiology, Immunology, and Pathology)
  • Chuck Henry, Ph.D. (Chemistry)
  • Mary Jackson, Ph.D. (Microbiology, Immunology, and Pathology)
  • Andrew Jones, Ph.D. (Cooperative Institute for Research in the Atmosphere)
  • Rebekah Kading, Ph.D. (Microbiology, Immunology, and Pathology)
  • Michael Kirby, Ph.D. (Mathematics)
  • Nicole Kruh-Garcia, Ph.D. (Microbiology, Immunology, and Pathology)
  • Hannah Love, Ph.D. (Science of Team Science, Institute for Research in Social Sciences)
  • Amy MacNeill, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Sheryl Magzamen, M.P.H., Ph.D. (Environmental and Radiological Health Sciences)
  • Christie Mayo, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Juan Munoz Guttierez, M.V.Z., Ph.D. (Microbiology, Immunology, and Pathology)
  • Andres Obregon Henao, Ph.D. (Microbiology, Immunology, and Pathology)
  • Kristy Pabalonia, D.V.M., Ph.D. (Clinical Diagnostics – Veterinary Health Systems)
  • Rushika Perera, Ph.D. (Microbiology, Immunology, and Pathology)
  • Brendan Podell, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Dan Regan, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Joel Rovnak, Ph.D. (Microbiology, Immunology, and Pathology)
  • Elizabeth Ryan, Ph.D. (Environmental and Radiological Health Sciences)
  • Tony Schountz, Ph.D. (Microbiology, Immunology, and Pathology)
  • Richard Slayden, Ph.D. (Microbiology, Immunology, and Pathology)
  • Chris Snow, Ph.D. (Chemical and Biological Engineering)
  • Mark Stenglein, Ph.D. (Microbiology, Immunology, and Pathology)
  • Ron Tjalkens, Ph.D. (Environmental and Radiological Health Sciences)
  • Sue VandeWoude, D.V.M. (One Health Institute at Colorado State University, Microbiology, Immunology, and Pathology)
  • Allison Vilander, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)
  • Zhijie Wang, Ph.D. (Mechanical Engineering)

The Role of the Prion Protein in Cancer

A definitive role for the prion protein remains elusive. We are capitalizing on unexpected properties recognized in affected cells to explore novel strategies to increase the response of cancer cells to certain therapeutic drugs.

Lead: Daniel Regan, D.V.M., Ph.D. (Microbiology, Immunology, and Pathology)

Members:

  • Jifeng Bian, D.M.D., Ph.D. (Microbiology, Immunology, and Pathology)
  • Lyndah Chow, M.S. (Clinical Sciences)
  • Steve Dow, D.V.M., Ph.D. (Clinical Sciences)
  • Soham Ghosh, Ph.D. (Mechanical Engineering)
  • Hannah Love, Ph.D. (Science of Team Science, Institute for Research in Social Sciences)
  • Candace Mathiason, Ph.D. (Microbiology, Immunology, and Pathology)
  • Juan Munoz Guttierez, M.V.Z., Ph.D. (Microbiology, Immunology, and Pathology)

Use of Mass Spectrometry for Immunological Assessment

The ability to fully characterize the immune response to infectious agents in certain animal models (bats, guinea pigs, deer, etc.) is hampered by a lack of reagents. To overcome this hurdle, we aim to generate highly sensitive and specific targeted mass spectrometry assays to detect and quantify immune proteins in complex matrices such as biological fluids and tissue homogenates.

Lead: Nicole Kruh-Garcia, Ph.D. (Microbiology, Immunology, and Pathology)

Members:

  • Steve Dow, D.V.M., Ph.D. (Clinical Sciences)
  • Tony Schountz, Ph.D. (Microbiology, Immunology, and Pathology)